Choosing Wisely: A neurosurgical perspective on Neuroimaging for headaches

Neurosurgery

Volumn 76, Issue 1, 2015, Pages 1-5

  Hawasli, Ammar H ^a   Chicoine, Michael R ^a   Dacey, Ralph G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Choosing wisely; Headaches; Magnetic resonance imaging; Neuroimaging

Indexed keywords

ARTICLE; BRAIN METASTASIS; BRAIN TUMOR; COGNITIVE DEFECT; COST BENEFIT ANALYSIS; COST CONTROL; EVIDENCE BASED PRACTICE; FUNDING; HEADACHE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HUMAN; INCIDENTAL FINDING; LYMPHOMA; MENINGIOMA; NEUROIMAGING; NEUROSURGEON; NEUROSURGERY; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEIZURE; SYMPTOM; BRAIN NEOPLASMS; COMPLICATION; ECONOMICS; PATIENT SELECTION; PHYSICIAN ATTITUDE; UNITED STATES;

BRAIN NEOPLASMS; COST CONTROL; HEADACHE; HUMANS; NEUROIMAGING; PATIENT SELECTION; PHYSICIAN'S ROLE; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84923259213     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000560     Document Type: Article

References (34)

1. Centers for Medicare &Medicaid Services. National Health Expenditures 2012 Highlights 2012. Available at http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/downloads/highlights.pdf. Accessed February 4, 2014.
2. World Health Organization. World Health Statistics 2011. Geneva, Switzerland: World Health Organization; 2011.
3. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol. 1991;44(11):1147-1157.
4. Ambulatory Sentinel Practice Network. A study of headache in North American primary care. J R Coll Gen Pract. 1987;37(302):400-403.
5. Evans RW. Diagnostic testing for migraine and other primary headaches. Neurol Clin. 2009;27(2):393-415.
6. Burke JF, Skolarus LE, Callaghan BC, Kerber KA. Choosing Wisely: highest-cost tests in outpatient neurology. Ann Neurol. 2013;73(5):679-683.
7. Loder E, Weizenbaum E, Frishberg B, Silberstein S; American Headache Society Choosing Wisely Task Force. Choosing Wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question. Headache. 2013;53(10):1651-1659.
8. American College of Radiology. Choosing Wisely: Five Things Patients and Physicians Should Question. Available at http://www.choosingwisely.org/doctor-patient-lists/american-college-of-radiology/. Accessed January 7, 2014.
9. Consumer Reports and ABIM Foundation. Choosing wisely: imaging tests for headaches. Available at: http://www.choosingwisely.org/doctor-patient-lists/imagingtests-for-headaches/. Accessed January 7, 2014.
10. Frishberg B, Rosenberg J, Matchar D, et al; American Academy of Neurology: US Headache Consortium. Evidence-Based Guidelines in the Primary Care Setting: Neuroimaging in Patients with Nonacute Headache. Available at: http://tools.aan. com/professionals/practice/pdfs/gl0088.pdf Accessed January 7, 2014.
11. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43(9):1678-1683.
12. Hawasli AH, Buckley RT, Gao F, et al. Biopsy of the superficial cortex: predictors of effectiveness and outcomes. Neurosurgery. 2013;73(2):224-231; discussion 231-232; quiz 232.
13. Callaghan BC, Kerber KA, Pace RJ, Skolarus LE, Burke JF. Headaches and neuroimaging: high utilization and costs despite guidelines. JAMA Intern Med. 2014;174(5):819-821.
14. Carrier ER, Reschovsky JD, Katz DA, Mello MM. High physician concern about malpractice risk predicts more aggressive diagnostic testing in office-based practice. Health Aff (Millwood). 2013;32(8):1383-1391.
15. Nahed BV, Babu MA, Smith TR, Heary RF. Malpractice liability and defensive medicine: a national survey of neurosurgeons. PLoS One. 2012;7(6): e39237.
16. Hermer LD, Brody H. Defensive medicine, cost containment, and reform. J Gen Intern Med. 2010;25(5):470-473.
17. Salem O, Forster C. Defensive medicine in general practice: recent trends and the impact of the Civil Liability Act 2002 (NSW). J Law Med. 2009;17(2): 235-248.
18. Rubin RJ, Mendelson DN. How much does defensive medicine cost? J Am Health Policy. 1994;4(4):7-15.
19. Stewart RM, Geoghegan K, Myers JG, et al. Malpractice risk and cost are significantly reduced after tort reform. J Am Coll Surg. 2011;212(4):463-467, 467. e1-467.e42; discussion 467-469.
20. Sidorov E, Reynolds M, Feng W, Selim M. Healthcare delivery to patients with cerebrovascular disease: cost-minimization analysis of CT vs. MRI in the evaluation of patients with transient ischemic attacks at a large academic center. Neurology. 2012;78(meeting abstracts 1):P05.224.
21. Carroll J. No informed consumers without price transparency. Manag Care. 2013; 22(10):17-18.
22. Auchter RM, Lamond JP, Alexander E, et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys. 1996;35(1):27-35.
23. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer. 1985;56(5):1106-1111.
24. Grant R, Liang BC, Page MA, Crane DL, Greenberg HS, Junck L. Age influences chemotherapy response in astrocytomas. Neurology. 1995;45(5):929-933.
25. Nelson JS, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J, Peress N. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer. 1983;52(3):550-554.
26. Rosenblum ML, Gerosa M, Dougherty DV, et al. Age-related chemosensitivity of stem cells from human malignant brain tumours. Lancet. 1982;1(8277): 885-887.
27. Wong ET, Hess KR, Gleason MJ, et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol. 1999; 17(8):2572-2578.
28. Callaghan BC, Burke JF, Feldman EL. How neurologists can choose (even more) wisely: prioritizing waste reduction targets and identifying gaps in knowledge. JAMA. 2014;311(16):1607-1608.
29. Fenton JJ, Jerant AF, Bertakis KD, Franks P. The cost of satisfaction: a national study of patient satisfaction, health care utilization, expenditures, and mortality. Arch Intern Med. 2012;172(5):405-411.
30. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293(16):1995-2002.
31. Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ. 1997;315(7117):1211-1214.
32. Jesse M, Pines J, Carpenter C, Raja A, Schuur JD. Clinical Decision Rules. Evidence-Based Emergency Care: Diagnostic Testing and Clinical Decision Rules. 2nd ed. Chichester, UK: John Wiley &Sons, Ltd.; 2013:36-43.
33. McGinn T, Guyatt G, Wyer P, Naylor CD, Stiell I. Diagnosis: clinical prediction rules. In: Guyatt G, Rennie D, Meade M, Cook D, eds. Users; Guides to the Medical Literature. New York, NY: McGraw-Hill Publishing Co; 2002: 471-483.
34. Stiell IG, Wells GA. Methodologic standards for the development of clinical decision rules in emergency medicine. Ann Emerg Med. 1999;33(4): 437-447.